Recombinant Human OSGIN1 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human OSGIN1 protein is a Human Full Length protein, in the 1 to 477 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
BDGI, OKL38, OSGIN1, Oxidative stress-induced growth inhibitor 1, Bone marrow stromal cell-derived growth inhibitor, Pregnancy-induced growth inhibitor OKL38, BMSC-derived growth inhibitor, huOKL38
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human OSGIN1 protein (AB162283)
ab162283 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The ability of OSGIN1 to regulate cell death allows it to maintain cellular homeostasis. This protein does not operate as part of a complex but performs its functions by altering the transcription of specific genes involved in cell growth and death. By modulating genes linked to oxidative damage OSGIN1 controls balance between cell survival and apoptosis thereby influencing cell fate in stressful environments.
Pathways
OSGIN1 plays a significant role in the oxidative stress response pathway by interacting with key proteins such as p53 and Nrf2. These interactions facilitate the antioxidant responses of cells. By promoting p53-mediated apoptosis and Nrf2-related antioxidant gene expression OSGIN1 helps in protecting cells from oxidative damage contributing to the proper functioning of related pathways.
Specifications
Form
Liquid
General info
Function
Regulates the differentiation and proliferation through the regulation of cell death.
Sequence similarities
Belongs to the OKL38 family.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com